Cancer-associated fibroblasts in gastrointestinal cancer.


Journal

Nature reviews. Gastroenterology & hepatology
ISSN: 1759-5053
Titre abrégé: Nat Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101500079

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 20 2 2019
medline: 20 7 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

The tumour microenvironment, also termed the tumour stroma or tumour mesenchyme, includes fibroblasts, immune cells, blood vessels and the extracellular matrix and substantially influences the initiation, growth and dissemination of gastrointestinal cancer. Cancer-associated fibroblasts (CAFs) are one of the critical components of the tumour mesenchyme and not only provide physical support for epithelial cells but also are key functional regulators in cancer, promoting and retarding tumorigenesis in a context-dependent manner. In this Review, we outline the emerging understanding of gastrointestinal CAFs with a particular emphasis on their origin and heterogeneity, as well as their function in cancer cell proliferation, tumour immunity, angiogenesis, extracellular matrix remodelling and drug resistance. Moreover, we discuss the clinical implications of CAFs as biomarkers and potential targets for prevention and treatment of patients with gastrointestinal cancer.

Identifiants

pubmed: 30778141
doi: 10.1038/s41575-019-0115-0
pii: 10.1038/s41575-019-0115-0
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

282-295

Subventions

Organisme : Medical Research Council
ID : MR/N005872/1
Pays : United Kingdom

Auteurs

Hiroki Kobayashi (H)

Adelaide Medical School, University of Adelaide and South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Atsushi Enomoto (A)

Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan. enomoto@iar.nagoya-u.ac.jp.

Susan L Woods (SL)

Adelaide Medical School, University of Adelaide and South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

Alastair D Burt (AD)

Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

Masahide Takahashi (M)

Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Daniel L Worthley (DL)

Adelaide Medical School, University of Adelaide and South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. Dan.Worthley@sahmri.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH